All lobbying filings

ABBOTT LABORATORIES

ABBOTT LABORATORIES filed a Q3 report for ABBOTT LABORATORIES on October 20, 2025.

Lobbying for ABBOTT LABORATORIES

All filings by ABBOTT LABORATORIES · Everything ABBOTT LABORATORIES has reported

Filing · LD-2 quarterly report Q3 report

Reporting period

3rd Quarter 2025

July 1 - Sep 30 · Posted Oct 20, 2025

Expenses

$1,128,989

What this organization spent lobbying with its own staff. Reported using the LDA's own definitions (method A): the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.

Client based in

District of Columbia

Official filing document

Government bodies contacted 7

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 7

Tariff (miscellaneous tariff bills)

Proposals related to tariffs on products imported into the United States. Proposals regarding US-China trade negotiations.

Law Enforcement/Crime/Criminal Justice

Proposals related to third party litigation reform.

Taxation/Internal Revenue Code

Proposals to reform domestic and international tax structures.

Health Issues

S. 2477/H.R. 1770 Equitable Community Access to Pharmacist Services Act. S. 2922/H.R. 7164 Advancing Research for Chronic Pain Act of 2024. Proposals related to digital health technologies and innovations. Proposals to advance policies related to effective pain management. Proposals related to the President's Emergency Plan for AIDS Relief (PEPFAR).

Medicare/Medicaid

S. 1000/H.R. 1835 Saving Access to Laboratory Services Act. Proposals regarding PAMA regulations and changes to modernize and update the Clinical Laboratory Fee Schedule. Proposals related to Medicare coverage of continuous glucose monitors.

Trade (domestic/foreign)

Proposals related to U.S. global health programs and pandemic preparedness. Proposals to advance global virus surveillance.

Agriculture

H.R. 2300 To ensure national uniformity with respect to certain requirements relating to preterm infant formula, and for other purposes. Proposals related to access to infant formula.

Bills named in this filing 7

S. 2477
Equitable Community Access to Pharmacist Services Act
H.R. 1770
Equitable Community Access to Pharmacist Services Act
S. 2922
Advancing Research for Chronic Pain Act of 2023
H.R. 7164
Advancing Research for Chronic Pain Act of 2024
S. 1000
Saving Access to Laboratory Services Act
H.R. 1835
Saving Access to Laboratory Services Act
H.R. 2300
To ensure national uniformity with respect to certain requirements relating to preterm infant formula, and for other pu…

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.